From systemic shotgun to site-specific nanoparticle-targeted delivery: a new paradigm for drug delivery.
Sarembock
Ian J
IJ
D000800:Angioplasty, Balloon / Q000009:adverse effects* / Q000295:instrumentation; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage* / Q000737:chemistry / Q000494:pharmacology; D050197:Atherosclerosis / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology / Q000628:therapy*; D001550:Benzamidines / Q000737:chemistry; D049109:Cell Proliferation / Q000187:drug effects; D003251:Constriction, Pathologic; D004195:Disease Models, Animal; D005227:Fatty Acids / Q000737:chemistry; D006801:Humans; D007083:Iliac Artery / Q000187:drug effects / Q000293:injuries; D007275:Injections, Intravenous; D008081:Liposomes; D008670:Metals; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000293:injuries / Q000378:metabolism / Q000473:pathology; D053758:Nanoparticles; D011239:Prednisolone / Q000008:administration & dosage* / Q000737:chemistry / Q000493:pharmacokinetics; D011474:Prosthesis Design; D055502:Secondary Prevention; D015607:Stents
C450860:3,5-dipentadecyloxybenzamidine hydrochloride; D000893:Anti-Inflammatory Agents; D001550:Benzamidines; D005227:Fatty Acids; D008081:Liposomes; D008670:Metals; D011239:Prednisolone